We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,306 hedge funds and large institutions have $72.6B invested in Thermo Fisher Scientific in 2018 Q1 according to their latest regulatory filings, with 139 funds opening new positions, 423 increasing their positions, 549 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 139 | Existing positions closed: 67

18% more funds holding in top 10

Funds holding in top 10: 89105 (+16)

8% more capital invested

Capital invested by funds: $67.1B → $72.6B (+$5.53B)

5% more funds holding

Funds holding: 1,2461,306 (+60)

0.54% less ownership

Funds ownership: 88.17%87.63% (-0.54%)

16% less call options, than puts

Call options by funds: $204M | Put options by funds: $242M

23% less repeat investments, than reductions

Existing positions increased: 423 | Existing positions reduced: 549

Holders
1,306
Holders Change
+60
Holders Change %
+4.82%
% of All Funds
29.93%
Holding in Top 10
105
Holding in Top 10 Change
+16
Holding in Top 10 Change %
+17.98%
% of All Funds
2.41%
New
139
Increased
423
Reduced
549
Closed
67
Calls
$204M
Puts
$242M
Net Calls
-$37.8M
Net Calls Change
+$96.4M
Name Holding Trade Value Shares
Change
Change in
Stake
BFS
176
Bradley Foster & Sargent
Connecticut
$40.6M -$1.26M -5,986 -3%
LWCFA
177
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$40.4M +$778K +3,705 +2%
WJA
178
Williams Jones & Associates
New York
$40.2M +$1.15M +5,487 +3%
William Blair Investment Management
179
William Blair Investment Management
Illinois
$40.2M -$12.2M -58,140 -23%
NA
180
Neuburgh Advisers
California
$40.1M -$83.1K -396 -0.2%
SFM
181
Soros Fund Management
New York
$39.8M +$28.4M +135,500 +236%
SC
182
Samlyn Capital
New York
$39.4M +$40.1M +190,842 New
FWCM
183
Ferguson Wellman Capital Management
Oregon
$39.4M -$474K -2,258 -1%
SLAM
184
Swiss Life Asset Management
$39.2M +$262K +1,247 +0.7%
PI
185
PGGM Investments
Netherlands
$38.9M
GVI
186
Green Valley Investors
Delaware
$38.9M
CS
187
Cannell & Spears
New York
$38.8M -$361K -1,720 -0.9%
WT
188
Washington Trust
Rhode Island
$38.1M -$2.77M -13,180 -7%
MMH
189
Menora Mivtachim Holdings
Israel
$37.4M +$12.6M +60,000 +49%
RFC
190
Regions Financial Corp
Alabama
$37.2M -$241K -1,146 -0.6%
JMPWA
191
JP Morgan Private Wealth Advisors
California
$36.5M +$421K +2,004 +1%
CCI
192
Columbus Circle Investors
$35.9M -$10.1M -48,128 -22%
SBH
193
Segall Bryant & Hamill
Illinois
$35.2M -$2.47M -11,748 -6%
Natixis Advisors
194
Natixis Advisors
Massachusetts
$35M +$2.2M +10,460 +7%
Aberdeen Group
195
Aberdeen Group
United Kingdom
$35M -$1.18M -5,645 -3%
CIPU
196
Caledonia Investments plc (UK)
United Kingdom
$34.9M
CIM
197
Confluence Investment Management
Missouri
$34.8M -$3.26M -15,544 -8%
TAM
198
Tocqueville Asset Management
New York
$34.6M -$1.65M -7,867 -4%
ACI
199
AMP Capital Investors
Australia
$34M -$1.79M -8,520 -5%
BNP Paribas Financial Markets
200
BNP Paribas Financial Markets
France
$33.9M +$5.47M +26,065 +19%

TMO Hedge Fund Activity: Q1 2018 in Review

1,306 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2018, worth a combined $72.6B — up 8.2% from $67.1B a quarter earlier.

Buyers outnumbered sellers: 139 funds opened new TMO positions and 67 closed out — a net gain of 72 holders — while 423 added to existing stakes and 549 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $305M. The largest seller was Massachusetts Financial Services, cutting an estimated $415M.

  • 1,306 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2018, up from 1,246 in Q4 2017.
  • Funds reported $72.6B of Thermo Fisher Scientific stock for Q1 2018, up 8.2% quarter-over-quarter.
  • 139 funds opened new Thermo Fisher Scientific positions in Q1 2018 and 67 closed out, a net change of +72 holders.
  • The largest Thermo Fisher Scientific buyer in Q1 2018 was Deutsche Bank, an estimated $305M added.
  • The largest Thermo Fisher Scientific seller in Q1 2018 was Massachusetts Financial Services, an estimated $415M sold.

Based on aggregated 13F filings for Q1 2018.